Roger J. Hajjar

Q: What Schools Are Affiliated With Roger J. Hajjar

Roger J. Hajjar is affiliated with the following schools: Medical University of Graz, Icahn School of Medicine at Mount Sinai, Case Western Reserve University, Columbia University, Massachusetts General Hospital

Roger J. Hajjar's AcademicInfluence.com Rankings

Roger J. Hajjar

Engineering

#3492

World Rank

#4579

Historical Rank

Biomedical Engineering

#169

World Rank

#174

Historical Rank

engineering Degrees

Roger J. Hajjar

Philosophy

#5017

World Rank

#7721

Historical Rank

Logic

#2367

World Rank

#3346

Historical Rank

philosophy Degrees

Download Badge

Engineering
Philosophy

Roger J. Hajjar's Degrees

PhD Biomedical Engineering Columbia University

Why Is Roger J. Hajjar Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Roger J. Hajjar's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Apoptosis in myocytes in end-stage heart failure. (1996) (1469)
Akt Activation Preserves Cardiac Function and Prevents Injury After Transient Cardiac Ischemia In Vivo (2001) (720)
Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure (2011) (659)
Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair (2007) (617)
Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy (2012) (612)
Accelerated Atherosclerosis, Aortic Aneurysm Formation, and Ischemic Heart Disease in Apolipoprotein E/Endothelial Nitric Oxide Synthase Double-Knockout Mice (2001) (609)
Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. (2000) (550)
Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. (1999) (507)
Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. (2009) (453)
Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure (2001) (453)
Modulation of Cardiac Contractility by the Phopholamban/SERCA2a Regulatome (2012) (434)
Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy (2000) (422)
Adenoviral gene transfer of activated phosphatidylinositol 3'-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. (1999) (392)
Improvement in Survival and Cardiac Metabolism After Gene Transfer of Sarcoplasmic Reticulum Ca2+-ATPase in a Rat Model of Heart Failure (2001) (385)
Functional consequences of caspase activation in cardiac myocytes (2002) (383)
Inhibition of miR-25 Improves Cardiac Contractility in the Failing Heart (2014) (375)
Titin Isoform Switch in Ischemic Human Heart Disease (2002) (361)
Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability (2016) (341)
Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure. (2008) (323)
Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics. (2019) (323)
Passive Stiffness Changes Caused by Upregulation of Compliant Titin Isoforms in Human Dilated Cardiomyopathy Hearts (2004) (314)
SUMO1-dependent modulation of SERCA2a in heart failure (2011) (313)
Modulation of ventricular function through gene transfer in vivo. (1998) (302)
Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. (1990) (282)
In Vivo Tracking of Stem Cells for Clinical Trials in Cardiovascular Disease (2004) (278)
Targeting Phospholamban by Gene Transfer in Human Heart Failure (2002) (278)
Resident c-kit+ cells in the heart are not cardiac stem cells (2015) (268)
Type 1 Phosphatase, a Negative Regulator of Cardiac Function (2002) (265)
Long-Term Effects of AAV1/SERCA2a Gene Transfer in Patients With Severe Heart Failure: Analysis of Recurrent Cardiovascular Events and Mortality (2014) (263)
FTO-Dependent N6-Methyladenosine Regulates Cardiac Function During Remodeling and Repair (2018) (254)
Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives. (2018) (242)
Therapeutic Cardiac‐Targeted Delivery of miR‐1 Reverses Pressure Overload–Induced Cardiac Hypertrophy and Attenuates Pathological Remodeling (2013) (232)
Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase. (2000) (232)
Long-Term Cardiac-Targeted RNA Interference for the Treatment of Heart Failure Restores Cardiac Function and Reduces Pathological Hypertrophy (2009) (226)
Enhancement of Cardiac Function and Suppression of Heart Failure Progression By Inhibition of Protein Phosphatase 1 (2005) (226)
Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes: implications for herceptin-induced cardiomyopathy. (2004) (222)
Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure. (2008) (220)
Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy. (1998) (218)
Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling. (2004) (217)
Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy. (2013) (216)
Contribution of abnormal sarcoplasmic reticulum ATPase activity to systolic and diastolic dysfunction in human heart failure. (1998) (216)
Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo (2001) (215)
Physiological effects of adenoviral gene transfer of sarcoplasmic reticulum calcium ATPase in isolated rat myocytes. (1997) (213)
CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury. (2007) (206)
Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH(2)-terminal kinases. (1999) (187)
Angiogenic Mechanisms of Human CD34+ Stem Cell Exosomes in the Repair of Ischemic Hindlimb (2017) (183)
Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle. (2011) (177)
Contractile deactivation and uncoupling of crossbridges. Effects of 2,3-butanedione monoxime on mammalian myocardium. (1991) (172)
AKT signalling in the failing heart (2011) (166)
SERCA2a Gene Transfer Decreases Sarcoplasmic Reticulum Calcium Leak and Reduces Ventricular Arrhythmias in a Model of Chronic Heart Failure (2011) (165)
Distinct Roles of MicroRNA-1 and -499 in Ventricular Specification and Functional Maturation of Human Embryonic Stem Cell-Derived Cardiomyocytes (2011) (165)
Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium (2014) (161)
Sarcoplasmic reticulum Ca2+ ATPase as a therapeutic target for heart failure (2010) (160)
Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial (2016) (160)
Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy (2015) (159)
Prospects for gene therapy for heart failure. (2000) (158)
SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway (2012) (154)
Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals. (2007) (148)
Critical Role for Stromal Interaction Molecule 1 in Cardiac Hypertrophy (2011) (148)
Small Molecule‐Mediated Directed Differentiation of Human Embryonic Stem Cells Toward Ventricular Cardiomyocytes (2014) (147)
Altered myocardial calcium cycling and energetics in heart failure--a rational approach for disease treatment. (2015) (144)
Altered sarcoplasmic reticulum calcium cycling—targets for heart failure therapy (2012) (142)
Neutralizing antibodies against AAV serotypes 1, 2, 6, and 9 in sera of commonly used animal models. (2012) (141)
Bone Morphogenetic Protein‐2 Decreases MicroRNA‐30b and MicroRNA‐30c to Promote Vascular Smooth Muscle Cell Calcification (2012) (137)
Cardiac Sodium Channel Gene Variants and Sudden Cardiac Death in Women (2008) (136)
Role of resistin in cardiac contractility and hypertrophy. (2008) (135)
JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure (2012) (135)
Design of a phase 2b trial of intracoronary administration of AAV1/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (calcium up-regulation by percutaneous administration of gene therapy in cardiac disease phase 2b). (2014) (132)
Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion (2016) (127)
The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases (2008) (127)
Shrink‐Film Configurable Multiscale Wrinkles for Functional Alignment of Human Embryonic Stem Cells and their Cardiac Derivatives (2011) (125)
Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins. (2007) (124)
Human heart failure: cAMP stimulation of SR Ca2+-ATPase activity and phosphorylation level of phospholamban. (1999) (124)
A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes. (2011) (123)
Damped elastic recoil of the titin spring in myofibrils of human myocardium (2003) (122)
Adenoviral gene transfer of phospholamban in isolated rat cardiomyocytes. Rescue effects by concomitant gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase. (1997) (122)
The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis. (2010) (122)
Targeted SERCA2a Gene Expression Identifies Molecular Mechanism and Therapeutic Target for Arrhythmogenic Cardiac Alternans (2009) (122)
Prevention of Ventricular Arrhythmias With Sarcoplasmic Reticulum Ca2+ ATPase Pump Overexpression in a Porcine Model of Ischemia Reperfusion (2008) (119)
Small Molecular Allosteric Activator of the Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA) Attenuates Diabetes and Metabolic Disorders* (2015) (118)
Ca2+ cycling and new therapeutic approaches for heart failure. (2010) (117)
Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology. (2009) (115)
Abnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome. (2014) (114)
A simple, cost-effective but highly efficient system for deriving ventricular cardiomyocytes from human pluripotent stem cells. (2014) (111)
Gene therapy for the treatment of heart failure: promise postponed. (2016) (107)
Ventricular Arrhythmias after Left Ventricular Assist Device Implantation (2008) (107)
Targeting calcium cycling proteins in heart failure through gene transfer (2003) (106)
Inducible Expression of Active Protein Phosphatase-1 Inhibitor-1 Enhances Basal Cardiac Function and Protects Against Ischemia/Reperfusion Injury (2009) (106)
Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy (2008) (105)
Targeted Sarcoplasmic Reticulum Ca2+ ATPase 2a Gene Delivery to Restore Electrical Stability in the Failing Heart (2012) (104)
Exosomal microRNA-21-5p Mediates Mesenchymal Stem Cell Paracrine Effects on Human Cardiac Tissue Contractility (2018) (104)
Relation between steady-state force and intracellular [Ca2+] in intact human myocardium. Index of myofibrillar responsiveness to Ca2+. (1990) (104)
Human heart failure: cAMP stimulation of SR Ca(2+)-ATPase activity and phosphorylation level of phospholamban. (1999) (101)
Systems Pharmacology of Adverse Event Mitigation by Drug Combinations (2013) (101)
Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure (2015) (100)
Delayed erythropoietin therapy reduces post-MI cardiac remodeling only at a dose that mobilizes endothelial progenitor cells. (2007) (100)
Sarco/Endoplasmic Reticulum Ca2+-ATPase Gene Transfer Reduces Vascular Smooth Muscle Cell Proliferation and Neointima Formation in the Rat (2005) (100)
Gene therapy: targeting the myocardium (2007) (99)
Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes (2017) (97)
Resistin Promotes Cardiac Hypertrophy via the AMP-activated Protein Kinase/Mammalian Target of Rapamycin (AMPK/mTOR) and c-Jun N-terminal Kinase/Insulin Receptor Substrate 1 (JNK/IRS1) Pathways* (2011) (95)
Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells. (2009) (95)
SUMO-1 Gene Transfer Improves Cardiac Function in a Large-Animal Model of Heart Failure (2013) (95)
Ca2+-ATPases in non-failing and failing heart: evidence for a novel cardiac sarco/endoplasmic reticulum Ca2+-ATPase 2 isoform (SERCA2c). (2006) (94)
Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes (2014) (93)
Plasticity of Surface Structures and &bgr;2-Adrenergic Receptor Localization in Failing Ventricular Cardiomyocytes During Recovery From Heart Failure (2012) (91)
CXCR4 modulates contractility in adult cardiac myocytes. (2006) (91)
Apoptosis in the failing heart. (1998) (91)
PICOT Inhibits Cardiac Hypertrophy and Enhances Ventricular Function and Cardiomyocyte Contractility (2006) (91)
Matricellular Protein CCN5 Reverses Established Cardiac Fibrosis. (2016) (90)
Characterization of right ventricular remodeling and failure in a chronic pulmonary hypertension model. (2014) (90)
Therapeutic Efficacy of AAV1.SERCA2a in Monocrotaline-Induced Pulmonary Arterial Hypertension (2013) (90)
Effect of protein kinase C activation on sarcoplasmic reticulum function and apparent myofibrillar Ca2+ sensitivity in intact and skinned muscles from normal and diseased human myocardium. (1990) (88)
Cross‐Bridge Dynamics in Human Ventricular Myocardium: Regulation of Contractility in the Failing Heart (1992) (88)
Effects of CXCR4 gene transfer on cardiac function after ischemia-reperfusion injury. (2010) (87)
Differential effect of DPI 201-106 on the sensitivity of the myofilaments to Ca2+ in intact and skinned trabeculae from control and myopathic human hearts. (1988) (87)
Mitral regurgitation augments post-myocardial infarction remodeling failure of hypertrophic compensation. (2008) (86)
SERCA2A overexpression decreases the incidence of aftercontractions in adult rabbit ventricular myocytes. (2001) (85)
Potential of gene therapy as a treatment for heart failure. (2013) (85)
Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade. (2005) (83)
Pkm2 Regulates Cardiomyocyte Cell Cycle and Promotes Cardiac Regeneration (2020) (82)
Quantitation of CXCR4 Expression in Myocardial Infarction Using 99mTc-Labeled SDF-1α (2008) (82)
Ca++ sensitizers impair cardiac relaxation in failing human myocardium. (1997) (82)
Cardiac Stim1 Silencing Impairs Adaptive Hypertrophy and Promotes Heart Failure Through Inactivation of mTORC2/Akt Signaling (2016) (80)
Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART‐1) trial design (2015) (79)
Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy (2015) (79)
PICOT Attenuates Cardiac Hypertrophy by Disrupting Calcineurin–NFAT Signaling (2008) (79)
Functional Near-Infrared Fluorescence Imaging for Cardiac Surgery and Targeted Gene Therapy (2002) (78)
Rescuing the failing heart by targeted gene transfer. (2011) (78)
Optimizing Cardiac Delivery of Modified mRNA. (2017) (75)
Gene therapy for heart failure. (2012) (75)
Corrigendum: Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability (2017) (73)
Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure (2015) (73)
Myocardial Delivery of Lipidoid Nanoparticle Carrying modRNA Induces Rapid and Transient Expression. (2016) (72)
Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells (2017) (72)
New Efficient Catheter-Based System for Myocardial Gene Delivery (2002) (72)
Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice (2017) (71)
Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo (2007) (71)
Transcoronary gene transfer of SERCA2a increases coronary blood flow and decreases cardiomyocyte size in a type 2 diabetic rat model. (2007) (70)
Gene Delivery of Sarcoplasmic Reticulum Calcium ATPase Inhibits Ventricular Remodeling in Ischemic Mitral Regurgitation (2010) (70)
β2-Adrenergic Receptor Signaling in the Cardiac Myocyte is Modulated by Interactions With CXCR4 (2010) (69)
Toll-like receptor 2 activation by bacterial peptidoglycan–associated lipoprotein activates cardiomyocyte inflammation and contractile dysfunction (2007) (68)
SERCA2a gene transfer enhances eNOS expression and activity in endothelial cells. (2010) (68)
RAF1 mutations in childhood-onset dilated cardiomyopathy (2014) (67)
Genomic correction of familial cardiomyopathy in human engineered cardiac tissues. (2016) (65)
Stem Cell Factor Gene Transfer Promotes Cardiac Repair After Myocardial Infarction via In Situ Recruitment and Expansion of c-kit+ Cells (2012) (65)
Long-term in vivo resistin overexpression induces myocardial dysfunction and remodeling in rats. (2011) (65)
PICOT is a critical regulator of cardiac hypertrophy and cardiomyocyte contractility. (2008) (65)
Cardiac gene therapy with SERCA2a: from bench to bedside. (2011) (64)
A novel mutant cardiac troponin C disrupts molecular motions critical for calcium binding affinity and cardiomyocyte contractility. (2008) (64)
Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT‐HF randomized phase 2 trial (2017) (64)
Apoptosis in heart failure and the senescent heart (2007) (64)
Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo (2007) (63)
Effect of engineered anisotropy on the susceptibility of human pluripotent stem cell-derived ventricular cardiomyocytes to arrhythmias. (2013) (63)
In Vivo Cardiac Gene Transfer of Kv4.3 Abrogates the Hypertrophic Response in Rats After Aortic Stenosis (2004) (63)
AAV9.I-1c Delivered via Direct Coronary Infusion in a Porcine Model of Heart Failure Improves Contractility and Mitigates Adverse Remodeling (2013) (63)
Cardiac I-1c overexpression with reengineered AAV improves cardiac function in swine ischemic heart failure. (2014) (63)
Potential Role of BNIP3 in Cardiac Remodeling, Myocardial Stiffness, and Endoplasmic Reticulum: Mitochondrial Calcium Homeostasis in Diastolic and Systolic Heart Failure (2013) (63)
Functional Near-Infrared Imaging for Cardiac Surgery and Targeted Gene Therapy (2002) (63)
Novel technique of aortic banding followed by gene transfer during hypertrophy and heart failure. (2002) (62)
Increased leakage of sarcoplasmic reticulum Ca2+ contributes to abnormal myocyte Ca2+ handling and shortening in sepsis* (2005) (62)
Early Repair of Moderate Ischemic Mitral Regurgitation Reverses Left Ventricular Remodeling: A Functional and Molecular Study (2007) (62)
In vivo volumetric analysis of coronary stent using optical coherence tomography with a novel balloon occlusion-flushing catheter: a comparison with intravascular ultrasound. (2005) (61)
FOXO3a regulates BNIP3 and modulates mitochondrial calcium, dynamics, and function in cardiac stress. (2016) (61)
Molecular aspects of adrenergic signal transduction in cardiac failure (1998) (61)
Noncyclooxygenase metabolites of arachidonic acid amplify the vasopressin-induced Ca2+ signal in glomerular mesangial cells by releasing Ca2+ from intracellular stores. (1991) (61)
Mitochondrial Morphology, Dynamics, and Function in Human Pressure Overload or Ischemic Heart Disease With Preserved or Reduced Ejection Fraction (2019) (61)
In vivo tracking in cardiac stem cell-based therapy. (2007) (60)
Family-Based Approaches to Cardiovascular Health Promotion. (2016) (60)
The role of SUMO-1 in cardiac oxidative stress and hypertrophy. (2014) (59)
Effects of Na+/Ca2+-exchanger Overexpression on Excitation–contraction Coupling in Adult Rabbit Ventricular Myocytes (2002) (58)
Expression of sarco (endo) plasmic reticulum calcium ATPase (SERCA) system in normal mouse cardiovascular tissues, heart failure and atherosclerosis. (2014) (58)
Angiotensin II-induced negative inotropy in rat ventricular myocytes: role of reactive oxygen species and p38 MAPK. (2006) (57)
Overwhelming evidence of the beneficial effects of SERCA gene transfer in heart failure. (2001) (57)
Cytosolic phospholipase A(2) regulates golgi structure and modulates intracellular trafficking of membrane proteins. (2000) (57)
Role of SIRT1 in Modulating Acetylation of the Sarco-Endoplasmic Reticulum Ca2+-ATPase in Heart Failure (2019) (57)
SERCA2a controls the mode of agonist-induced intracellular Ca2+ signal, transcription factor NFAT and proliferation in human vascular smooth muscle cells. (2011) (56)
Human Cardiac Gene Therapy (2018) (56)
Inhibition of PKC&agr;/&bgr; With Ruboxistaurin Antagonizes Heart Failure in Pigs After Myocardial Infarction Injury (2011) (56)
The role of microRNAs in cardiac development and regenerative capacity. (2016) (56)
SERCA2a in Heart Failure: Role and Therapeutic Prospects (2005) (55)
Localization and Quantification of Platelet-Rich Thrombi in Large Blood Vessels With Near-Infrared Fluorescence Imaging (2006) (54)
Mechanical and metabolic rescue in a type II diabetes model of cardiomyopathy by targeted gene transfer. (2006) (54)
Stimulating Myocardial Regeneration with Periostin Peptide in Large Mammals Improves Function Post-Myocardial Infarction but Increases Myocardial Fibrosis (2013) (54)
Left Ventricular Unloading Using an Impella CP Improves Coronary Flow and Infarct Zone Perfusion in Ischemic Heart Failure (2018) (52)
Myofilament calcium regulation in human myocardium. (2000) (52)
miR-146a Suppresses SUMO1 Expression and Induces Cardiac Dysfunction in Maladaptive Hypertrophy (2018) (51)
Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response After Myocardial Infarction (2020) (51)
Physiologic, Pathologic, and Therapeutic Paracrine Modulation of Cardiac Excitation-Contraction Coupling (2018) (50)
Myocyte-depleted engineered cardiac tissues support therapeutic potential of mesenchymal stem cells. (2012) (50)
Long-term angiotensin-converting enzyme inhibition with fosinopril improves depressed responsiveness to Ca2+ in myocytes from aortic-banded rats. (1996) (50)
Intratracheal Gene Delivery of SERCA2a Ameliorates Chronic Post-Capillary Pulmonary Hypertension: A Large Animal Model. (2016) (49)
Deletion of delta-like 1 homologue accelerates fibroblast–myofibroblast differentiation and induces myocardial fibrosis (2019) (49)
Experimental and Computational Insight Into Human Mesenchymal Stem Cell Paracrine Signaling and Heterocellular Coupling Effects on Cardiac Contractility and Arrhythmogenicity (2017) (49)
Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates (2009) (49)
Gene therapy in the treatment of heart failure. (2007) (49)
Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences. (2008) (48)
Comparison of nonuniform rotational distortion between mechanical IVUS and OCT using a phantom model. (2007) (47)
Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy. (2010) (47)
Decreased Efficiency of Adenovirus-Mediated Gene Transfer in Aging Cardiomyocytes (2003) (46)
SERCA2a gene transfer improves electrocardiographic performance in aged mdx mice (2011) (45)
Intracellular calcium related to force development in twitch contraction of mammalian myocardium. (1990) (45)
In vivo myocardial distribution of multipotent progenitor cells following intracoronary delivery in a swine model of myocardial infarction. (2009) (44)
Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure (2010) (44)
Molecular targets in heart failure gene therapy: current controversies and translational perspectives (2012) (43)
KChIP2 attenuates cardiac hypertrophy through regulation of Ito and intracellular calcium signaling. (2008) (43)
Rescue of Ca2+ overload-induced left ventricular dysfunction by targeted ablation of phospholamban. (2009) (43)
Assessing left ventricular systolic dysfunction after myocardial infarction: are ejection fraction and dP/dt(max) complementary or redundant? (2012) (42)
Mechanoelectrical remodeling and arrhythmias during progression of hypertrophy (2010) (42)
In vivo gene transfer of parvalbumin improves diastolic function in aged rat hearts. (2005) (41)
Adrenergic-receptor polymorphisms and heart failure. (2002) (41)
Increased Stiffness Is the Major Early Abnormality in a Pig Model of Severe Aortic Stenosis and Predisposes to Congestive Heart Failure in the Absence of Systolic Dysfunction (2015) (41)
Targeted gene transfer increases contractility and decreases oxygen cost of contractility in normal rat hearts. (2007) (41)
Targeting protein-protein interactions for therapeutic discovery via FRET-based high-throughput screening in living cells (2018) (41)
Effectiveness of gene delivery systems for pluripotent and differentiated cells (2015) (40)
SDF-1 induces TNF-mediated apoptosis in cardiac myocytes (2017) (40)
Altered Ca2+ sparks and gating properties of ryanodine receptors in aging cardiomyocytes. (2005) (40)
Cellular and molecular remodeling in a heart failure model treated with the β-blocker carteolol. (1999) (40)
Tracking stem cells in the cardiovascular system. (2005) (39)
Gene delivery methods in cardiac gene therapy (2011) (39)
Adeno-associated virus-mediated gene therapy in cardiovascular disease (2015) (38)
Characterizing preclinical models of ischemic heart failure: differences between LAD and LCx infarctions. (2014) (38)
Differential patterns of replacement and reactive fibrosis in pressure and volume overload are related to the propensity for ischaemia and involve resistin (2013) (37)
Mesenchymal stem cells in the infarcted heart (2005) (37)
Late Repair of Ischemic Mitral Regurgitation Does Not Prevent Left Ventricular Remodeling: Importance of Timing for Beneficial Repair (2012) (37)
Functional Human Beige Adipocytes From Induced Pluripotent Stem Cells (2017) (37)
Potential Role of BNIP3 in Cardiac Remodeling, Myocardial Stiffness, and Endoplasmic ReticulumClinical Perspective (2013) (36)
Calcium Cycling Proteins and Their Association With Heart Failure (2011) (36)
Modulation of action potential duration on myocyte hypertrophic pathways. (2006) (35)
High-dose chloroquine is metabolically cardiotoxic by inducing lysosomes and mitochondria dysfunction in a rat model of pressure overload hypertrophy (2015) (35)
Myocardial stunning in hyperthyroidism (2000) (35)
Functional alterations in adult rat myocytes after overexpression of phospholamban with use of adenovirus. (1999) (35)
Signaling pathways mediating the response to hypertrophic stress in the heart. (1999) (35)
Alternatively Spliced Tissue Factor Promotes Plaque Angiogenesis Through the Activation of Hypoxia-Inducible Factor-1&agr; and Vascular Endothelial Growth Factor Signaling (2014) (35)
Direct evidence of changes in myofilament responsiveness to Ca2+ during hypoxia and reoxygenation in myocardium. (1990) (35)
Mechanisms of Abnormal Calcium Homeostasis in Mutations Responsible for Catecholaminergic Polymorphic Ventricular Tachycardia (2007) (35)
Concomitant intravenous nitroglycerin with intracoronary delivery of AAV1.SERCA2a enhances gene transfer in porcine hearts. (2012) (34)
A new model of congestive heart failure in rats. (2011) (34)
Na+/Ca2+ exchanger-1 protects against systolic failure in the Akitains2 model of diabetic cardiomyopathy via a CXCR4/NF-κB pathway. (2012) (34)
Cardiac-specific gene expression facilitated by an enhanced myosin light chain promoter. (2004) (33)
Targeted gene therapy for the treatment of heart failure. (2011) (33)
Stem Cell Factor Gene Transfer Improves Cardiac Function After Myocardial Infarction in Swine (2012) (33)
Gene Transfer of Parvalbumin Improves Diastolic Dysfunction in Senescent Myocytes (2004) (33)
Effects of Na(+)/Ca(2+)-exchanger overexpression on excitation-contraction coupling in adult rabbit ventricular myocytes. (2002) (33)
Child Health Promotion in Underserved Communities: The FAMILIA Trial. (2019) (33)
miR-25 Tough Decoy Enhances Cardiac Function in Heart Failure. (2017) (32)
Pathophysiological and biochemical characterisation of an avian model of dilated cardiomyopathy: comparison to findings in human dilated cardiomyopathy. (1993) (32)
Global genome analysis reveals a vast and dynamic anellovirus landscape within the human virome. (2021) (32)
Swine Model of Chronic Postcapillary Pulmonary Hypertension with Right Ventricular Remodeling: Long-Term Characterization by Cardiac Catheterization, Magnetic Resonance, and Pathology (2014) (32)
Overexpression of sorcin enhances cardiac contractility in vivo and in vitro. (2005) (31)
Expression of active protein phosphatase 1 inhibitor-1 attenuates chronic beta-agonist-induced cardiac apoptosis (2010) (31)
Aortic implantation of mesenchymal stem cells after aneurysm injury in a porcine model. (2011) (31)
Gene Remodeling in Type 2 Diabetic Cardiomyopathy and Its Phenotypic Rescue with SERCA2a (2009) (31)
Cellular and molecular remodeling in a heart failure model treated with the beta-blocker carteolol. (1999) (31)
CXCR4 gene transfer prevents pressure overload induced heart failure. (2012) (30)
Guidelines for Translational Research in Heart Failure (2015) (30)
Atrial Infarction and Ischemic Mitral Regurgitation Contribute to Post-MI Remodeling of the Left Atrium. (2017) (30)
Phospholamban as a Crucial Determinant of the Inotropic Response of Human Pluripotent Stem Cell–Derived Ventricular Cardiomyocytes and Engineered 3-Dimensional Tissue Constructs (2015) (30)
Oscillations of intracellular calcium induced by vasopressin in individual fura-2-loaded mesangial cells. Frequency dependence on basal calcium concentration, agonist concentration, and temperature. (1991) (30)
Differences in cardioprotective efficacy of adrenergic receptor antagonists and Ca2+ channel antagonists in an animal model of dilated cardiomyopathy. Effects on gross morphology, global cardiac function, and twitch force. (1993) (30)
Imaging in cardiac cell-based therapy: in vivo tracking of the biological fate of therapeutic cells (2008) (29)
Overexpression of SERCA2a accelerates repolarisation in rabbit ventricular myocytes. (2002) (29)
Percutaneous Approaches for Efficient Cardiac Gene Delivery (2013) (29)
SERCA 2 a Gene Transfer Decreases Sarcoplasmic Reticulum Calcium Leak and Reduces Ventricular Arrhythmias in a Model of Chronic Heart Failure (2011) (29)
Assessment of Cardiovascular Fibrosis Using Novel Fluorescent Probes (2011) (28)
Introducing Genes to the Heart: All About Delivery (2017) (28)
Quantification of AAV particle titers by infrared fluorescence scanning of coomassie-stained sodium dodecyl sulfate-polyacrylamide gels. (2012) (28)
Xanthine oxidase inhibition and heart failure: novel therapeutic strategy for ventricular dysfunction? (2006) (28)
Gene profiling during regression of pressure overload-induced cardiac hypertrophy. (2007) (28)
Chronic treatment with Carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure (2003) (27)
Protein Phosphatase Inhibitor-1 Gene Therapy in a Swine Model of Nonischemic Heart Failure. (2017) (27)
Targeting sarcoplasmic reticulum calcium ATPase by gene therapy. (2013) (26)
Selective regulation of cyclic nucleotide phosphodiesterase PDE3A isoforms (2013) (26)
Cardiac surgical delivery of the sarcoplasmic reticulum calcium ATPase rescues myocytes in ischemic heart failure. (2013) (26)
Intracellular devastation in heart failure (2008) (26)
PICOT increases cardiac contractility by inhibiting PKCζ activity. (2012) (26)
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Human Medium- and Large-Sized Arteries (2018) (25)
Long-Term Effects of AAV1/SERCA2a Gene Transfer in Patients With Severe Heart FailureNovelty and Significance (2014) (25)
Molecular Imaging of Apoptosis in Ischemia Reperfusion Injury With Radiolabeled Duramycin Targeting Phosphatidylethanolamine: Effective Target Uptake and Reduced Nontarget Organ Radiation Burden. (2018) (25)
Up‐regulation of micro‐RNA765 in human failing hearts is associated with post‐transcriptional regulation of protein phosphatase inhibitor‐1 and depressed contractility (2015) (25)
Effect of a high omega-3 fatty acid diet on cardiac contractile performance in Oncorhynchus mykiss. (1996) (24)
High capsid-genome correlation facilitates creation of AAV libraries for directed evolution. (2015) (24)
Interaction between increased SERCA2a activity and beta -adrenoceptor stimulation in adult rabbit myocytes. (2002) (24)
Post-translational Modifications in Heart Failure: Small Changes, Big Impact. (2016) (24)
Benefit of SERCA2a gene transfer to vascular endothelial and smooth muscle cells: a new aspect in therapy of cardiovascular diseases. (2013) (24)
Cardiac Stim 1 Silencing Impairs Adaptive Hypertrophy and Promotes Heart Failure Through Inactivation of mTORC 2 / Akt Signaling (2016) (23)
Apolipoprotein E deficiency abrogates insulin resistance in a mouse model of type 2 diabetes mellitus (2009) (23)
SERCA2a gene transfer prevents intimal proliferation in an organ culture of human internal mammary artery (2012) (23)
Synergistic Role of Protein Phosphatase Inhibitor 1 and Sarco/Endoplasmic Reticulum Ca2+-ATPase in the Acquisition of the Contractile Phenotype of Arterial Smooth Muscle Cells (2014) (23)
Effect of Bortezomib on the Efficacy of AAV9.SERCA2a Treatment to Preserve Cardiac Function in a Rat Pressure-Overload Model of Heart Failure (2014) (23)
EMPAGLIFLOZIN INDUCES A MYOCARDIAL METABOLIC SHIFT FROM GLUCOSE CONSUMPTION TO KETONE METABOLISM THAT MITIGATES ADVERSE CARDIAC REMODELING AND IMPROVES MYOCARDIAL CONTRACTILITY (2018) (23)
Calcium-activated force in a turkey model of spontaneous dilated cardiomyopathy: adaptive changes in thin myofilament Ca2+ regulation with resultant implications on contractile performance. (1992) (23)
Cyclosporine attenuates cardiomyocyte hypertrophy induced by RAF1 mutants in Noonan and LEOPARD syndromes. (2011) (23)
Mechanism of action of 2,3-butanedione monoxime on contracture during metabolic inhibition. (1994) (22)
Variability in coronary artery anatomy affects consistency of cardiac damage after myocardial infarction in mice. (2017) (22)
Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes. (2018) (21)
Development of a preclinical model of ischemic cardiomyopathy in swine. (2011) (21)
Acute Left Ventricular Unloading Reduces Atrial Stretch and Inhibits Atrial Arrhythmias. (2018) (21)
Cardiac adenylyl cyclase overexpression precipitates and aggravates age-related myocardial dysfunction. (2019) (21)
Mitigation of myocardial fibrosis by molecular cardiac surgery-mediated gene overexpression. (2016) (21)
Comparison of echocardiographic measurements of left ventricular volumes to full volume magnetic resonance imaging in normal and diseased rats. (2013) (21)
Mitochondrial Integrity and Function in the Progression of Early Pressure Overload–Induced Left Ventricular Remodeling (2017) (21)
Concurrent upregulation of endogenous proapoptotic and antiapoptotic factors in failing human hearts (2009) (20)
The transcription factor Eya2 prevents pressure overload-induced adverse cardiac remodeling. (2009) (20)
The Phospholamban Journey 4 Decades After Setting Out for Ithaka. (2017) (20)
Dominant negative Ras attenuates pathological ventricular remodeling in pressure overload cardiac hypertrophy. (2015) (20)
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 17-2002. A 55-year-old man with second-degree atrioventricular block and chest pain. (2002) (20)
Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy (2013) (20)
Targeting Ca2+ cycling proteins and the action potential in heart failure by gene transfer (2002) (20)
Calcineurin inhibitors and cardiac hypertrophy (1999) (19)
Transcriptional changes following restoration of SERCA2a levels in failing rat hearts (2004) (19)
Molecular targets of current and prospective heart failure therapies (2013) (19)
Use of Adeno-Associated Virus Vector for Cardiac Gene Delivery in Large-Animal Surgical Models of Heart Failure. (2017) (19)
Cytokine-Like 1 Regulates Cardiac Fibrosis via Modulation of TGF-β Signaling (2016) (19)
Efficient viral gene transfer to rodent hearts in vivo. (2003) (19)
AAV1.SERCA2a Gene Therapy Reverses Pulmonary Fibrosis by Blocking the STAT3/FOXM1 Pathway and Promoting the SNON/SKI Axis. (2019) (19)
Gene transfer for ischemic heart failure in a preclinical model. (2011) (18)
Pericardial Fluid Exosomes: A New Material to Treat Cardiovascular Disease. (2017) (18)
Gene transfer in cardiac myocytes. (2004) (18)
HAX-1 regulates SERCA2a oxidation and degradation. (2018) (18)
CXCR4 and CXCR7 play distinct roles in cardiac lineage specification and pharmacologic β-adrenergic response (2017) (18)
The force-interval relationship in human myocardium. (1995) (18)
Transcription coactivator Eya2 is a critical regulator of physiological hypertrophy. (2012) (18)
Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKC&agr;/Gal‐3 pathway reduces left ventricular fibrosis following myocardial infarction (2018) (18)
Axial stretch-dependent cation entry in dystrophic cardiomyopathy: Involvement of several TRPs channels. (2016) (18)
Mechanical work and energetic analysis of eccentric cardiac remodeling in a volume overload heart failure in rats. (2009) (18)
Gene Therapy in Cardiac Surgery: Clinical Trials, Challenges, and Perspectives. (2016) (17)
Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension. (2019) (17)
Pulmonary Artery Hypertension Model in Rats by Monocrotaline Administration. (2018) (17)
Active Inhibitor-1 Maintains Protein Hyper-Phosphorylation in Aging Hearts and Halts Remodeling in Failing Hearts (2013) (17)
Targeted Gene Delivery through the Respiratory System: Rationale for Intratracheal Gene Transfer (2019) (16)
Increased Afterload Following Myocardial Infarction Promotes Conduction-Dependent Arrhythmias That Are Unmasked by Hypokalemia (2017) (16)
Sarco (Endo) Plasmic Reticulum Calcium Atpases (SERCA) Isoforms in the Normal and Diseased Cardiac, Vascular and Skeletal Muscle (2013) (16)
CXCR4 Cardiac Specific Knockout Mice Develop a Progressive Cardiomyopathy (2019) (16)
Stroke volume-to-wall stress ratio as a load-adjusted and stiffness-adjusted indicator of ventricular systolic performance in chronic loading. (2012) (16)
The Sugen 5416/Hypoxia Mouse Model of Pulmonary Arterial Hypertension. (2018) (15)
Allele-Specific Silencing Ameliorates Restrictive Cardiomyopathy Due to a Human Myosin Regulatory Light Chain Mutation. (2019) (15)
Cardiopoietic stem cell therapy in ischaemic heart failure: long‐term clinical outcomes (2020) (15)
Experimental models of cardiac physiology and pathology (2019) (15)
Molecular components of transient outward potassium current in cultured neonatal rat ventricular myocytes (2002) (15)
Gene Therapy for Heart Failure: Where Do We Stand? (2013) (15)
Responsiveness of the myofilaments to Ca2+ in human heart failure: implications for Ca2+ and force regulation. (1992) (15)
Modulation of calcium-activation in control and pressure--overload hypertrophied ferret hearts: effect of DPI 201-106 on myofilament calcium responsiveness. (1991) (15)
Combination Proximal Pulmonary Artery Coiling and Distal Embolization Induces Chronic Elevations in Pulmonary Artery Pressure in Swine (2015) (15)
Calcium-sensitizing inotropic agents in the treatment of heart failure: A critical view (1991) (15)
Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy. (2020) (15)
Cardiac Gene Therapy: From Concept to Reality (2012) (15)
Rationale and Design of Family‐Based Approach in a Minority Community Integrating Systems–Biology for Promotion of Health (FAMILIA) (2017) (15)
Contractile effects of adenovirally-mediated increases in SERCA2a activity: A comparison between adult rat and rabbit ventricular myocytes (2003) (15)
Abnormalities of capillary microarchitecture in a rat model of coronary ischemic congestive heart failure. (2015) (15)
Ventricular pressure and dimension measurements in mice. (1999) (14)
Safety and long-term efficacy of AAV1.SERCA2a using nebulizer delivery in a pig model of pulmonary hypertension (2018) (14)
Sarcoplasmic reticulum and calcium cycling targeting by gene therapy (2012) (14)
Treatment of heart failure by calcium cycling gene therapy. (2007) (14)
Decoy peptides targeted to protein phosphatase 1 inhibit dephosphorylation of phospholamban in cardiomyocytes. (2013) (14)
Progressive nature of chronic mitral regurgitation and the role of tissue Doppler-derived indexes. (2008) (14)
[Ca2+]i in human heart failure: a review and discussion of current areas of controversy. (1994) (14)
A pilot study of a new chicken model of alcohol-induced cardiomyopathy. (1999) (13)
AAV-Mediated Knock-Down of HRC Exacerbates Transverse Aorta Constriction-Induced Heart Failure (2012) (13)
Na / Ca 2 exchanger-1 protects against systolic failure in the Akitains 2 model of diabetic cardiomyopathy via a CXCR 4 / NF-B pathway (2012) (13)
Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy. (2007) (13)
Abstract 10606: Plasticity of Surface Structures and Beta 2-adrenergic Receptor Localization in Failing Ventricular Cardiomyocytes During Recovery From Heart Failure (2011) (12)
Cardiac-Specific Gene Expression Facilitated by an Enhanced Myosin Light Chain Promoter (2004) (12)
RESISTIN AGGRAVATES ATHEROSCLEROSIS IN APOE-/- MICE AND IS ELEVATED IN HUMAN ATHEROSCLEROTIC LESIONS (2019) (12)
Mitral Valve Prolapse: A Disease of Valve and Ventricle. (2018) (12)
Human G109E-inhibitor-1 impairs cardiac function and promotes arrhythmias. (2015) (12)
Comparison of Left Ventricular Stroke Volume Assessment by Two‐ and Three‐Dimensional Echocardiography in a Swine Model of Acute Myocardial Infarction Validated by Thermodilution Method (2012) (12)
Cardiac gene therapy. (2010) (11)
Molecules linked to Ras signaling as therapeutic targets in cardiac pathologies (2021) (11)
Safe and Sustained Overexpression of Functional Apolipoprotein A-I/High-density Lipoprotein in Apolipoprotein A-I–null Mice by Muscular Adeno-associated Viral Serotype 8 Vector Gene Transfer (2009) (11)
A novel secreted-cAMP pathway inhibits pulmonary hypertension via a feed-forward mechanism. (2019) (11)
Direct reprogramming induces vascular regeneration post muscle ischemic injury (2021) (10)
Clopidogrel and CYP2C19 testing: ready for clinical prime time? (2012) (10)
Therapeutic Efficacy of AAV 1 . SERCA 2 a in Monocrotaline-Induced Pulmonary Arterial Hypertension (2013) (10)
Calcium Cycling in Synthetic and Contractile Phasic or Tonic Vascular Smooth Muscle Cells (2012) (10)
A series of robust genetic indicators for definitive identification of cardiomyocytes. (2016) (9)
Modeling CVD in human pluripotent cells by genome editing. (2014) (9)
Alternatively Spliced Tissue Factor Promotes Plaque Angiogenesis Through the Activation of HIF-1α and VEGF Signaling (2014) (9)
A Pig Model of Myocardial Infarction: Catheter-Based Approaches. (2018) (9)
Heart Failure: A Silver bullet to treat heart failure (2006) (9)
Candesartan abrogates G protein-coupled receptors agonist-induced MAPK activation and cardiac myocyte hypertrophy (2001) (9)
Adult human cardiac stem cell supplementation effectively increases contractile function and maturation in human engineered cardiac tissues (2019) (9)
Adeno-associated Virus Serotype 8 ApoA-I Gene Transfer Reduces Progression of Atherosclerosis in ApoE-KO Mice: Comparison of Intramuscular and Intravenous Administration (2011) (9)
Yin-Yang 1 transcription factor modulates ST2 expression during adverse cardiac remodeling post-myocardial infarction. (2019) (9)
AAV vectors and cardiovascular disease: Targeting TNF receptor in the heart: clue to way forward with AAV? (2007) (9)
Abstract 15439: AAV-Containing Exosomes as a Novel Vector to Improve AAV-Mediated Myocardial Gene Delivery in Resistance to Neutralizing Antibody (2017) (8)
Gene therapies for arrhythmias in heart failure (2014) (8)
Angiotensin II-induced negative inotropy in rat ventricular myocytes : role of reactive oxygen species and p 38 MAPK (2005) (8)
Surgical and physiological challenges in the development of left and right heart failure in rat models (2019) (8)
PRESERVATION OF MECHANICAL AND ENERGETIC FUNCTION AFTER ADENOVIRAL GENE TRANSFER IN NORMAL RAT HEARTS (2007) (8)
Targeted gene transfer in heart failure: implications for novel gene identification. (2004) (8)
Speckle-Tracking Echocardiographic Strain Analysis Reliably Estimates Degree of Acute LV Unloading During Mechanical LV Support by Impella (2018) (8)
Conventional Method of Transverse Aortic Constriction in Mice. (2018) (8)
Fingerprint profile of alcohol-associated heart failure in human hearts. (2008) (8)
Ischemic Model of Heart Failure in Rats and Mice. (2018) (8)
The impact of pressure overload on coronary vascular changes following myocardial infarction in rats. (2013) (8)
Adverse effects of hydroxychloroquine and azithromycin on contractility and arrhythmogenicity revealed by human engineered cardiac tissues (2020) (7)
A role for calcium in resistin transcriptional activation in diabetic hearts (2018) (7)
Mesenchymal Stem Cells & Endothelial Function (2015) (7)
The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats. (2019) (7)
Modulation of chromatin remodeling proteins SMYD1 and SMARCD1 promotes contractile function of human pluripotent stem cell-derived ventricular cardiomyocyte in 3D-engineered cardiac tissues (2019) (7)
Temporal changes of strain parameters in the progress of chronic ischemia: with comparison to transmural infarction (2012) (7)
Gene therapy for the treatment of catecholaminergic polymorphic ventricular tachycardia. (2014) (7)
Comparison of Incidences of Congestive Heart Failure in Older African-Americans, Hispanics, and Whites (1999) (7)
Specific Modified mRNA Translation System. (2020) (7)
Chronic Erythropoietin Treatment Decreases Post-Infarct Myocardial Damage in Rats without Venous Thrombogenic Effect (2008) (7)
Clinical correlates of the myocardial force-frequency relationship in patients with end-stage heart failure. (1997) (7)
Primary Effect of SERCA2a Gene Transfer on Conduction Reserve in Chronic Myocardial Infarction (2018) (7)
Tracking stem cells in vivo. (2006) (7)
Telomerase and the aging heart. (2003) (7)
Echocardiographic and hemodynamic assessment for predicting early clinical events in severe acute mitral regurgitation (2018) (7)
THE SGLT2 INHIBITOR EMPAGLIFLOZIN DOES NOT EXHIBIT PRO THROMBOTIC EFFECTS (2018) (6)
Gene Therapy for Heart Failure (2012) (6)
Gene therapy for the treatment of heart failure--calcium signaling. (2003) (6)
Extrapericardial cardiac tamponade after blunt chest trauma. (1995) (6)
Effects of pH and temperature on myocardial calcium-activation in Pterygoplichthys (catfish) (1998) (6)
Therapeutic Delivery of Pip4k2c‐Modified mRNA Attenuates Cardiac Hypertrophy and Fibrosis in the Failing Heart (2021) (6)
Cardiac cell and gene therapies: two trajectories, one goal (2008) (6)
Gene therapy for heart failure. (2001) (6)
Impaired Right Ventricular Calcium Cycling Is an Early Risk Factor in R14del-Phospholamban Arrhythmias (2021) (6)
Arrhythmia Mechanism and Dynamics in a Humanized Mouse Model of Inherited Cardiomyopathy Caused by Phospholamban R14del Mutation (2021) (6)
The Probability of Inconstancy in Assessment of Cardiac Function Post-Myocardial Infarction in Mice (2016) (6)
Stem cell therapy for acute myocardial infarction: on the horizon or still a dream? (2017) (6)
Cardiac Gene Delivery in Large Animal Models: Antegrade Techniques. (2017) (6)
Generation of Efficient miRNA Inhibitors Using Tough Decoy Constructs. (2017) (6)
Role of the PRC2-Six1-miR-25 signaling axis in heart failure. (2019) (6)
Intracellular Free Calcium in Hypertrophy and Failure (1994) (5)
Myocardial delivery of stromal cell-derived factor 1 in patients with ischemic heart disease: safe and promising. (2013) (5)
Transgenic models of heart failure: elucidation of the molecular mechanisms of heart disease. (2005) (5)
Advances in Gene-Based Therapy for Heart Failure (2008) (5)
Method of gene delivery in large animal models of cardiovascular diseases. (2011) (5)
Progress in Gene Therapy for Heart Failure (2014) (5)
Allele-specific silencing ameliorates restrictive cardiomyopathy due to a human myosin regulatory light chain mutation (2019) (5)
Heart Function Challenged with β-Receptor Agonism or Antagonism in a Heart Failure Model (2001) (5)
A Calsequestrin Cis-Regulatory Motif Coupled to a Cardiac Troponin T Promoter Improves Cardiac Adeno-Associated Virus Serotype 9 Transduction Specificity. (2018) (5)
Labeling galectin-3 for the assessment of myocardial infarction in rats (2014) (5)
Synthetic MicroRNAs Stimulate Cardiac Repair. (2017) (5)
PLN Foundation. (2018) (5)
Cellular and molecular remodeling in a heart failure model treated with the b-blocker carteolol (1999) (5)
Current Methods in Cardiac Gene Therapy: Overview. (2017) (5)
Basic Concepts in Heart Failure Ca 2 Cycling and New Therapeutic Approaches for Heart Failure (2010) (5)
Refilling Intracellular Calcium Stores. (2010) (5)
Enhancing atrial‐specific gene expression using a calsequestrin cis‐regulatory module 4 with a sarcolipin promoter (2018) (5)
3D-ECHOCARDIOGRAPHY DEMONSTRATES EXCELLENT CORRELATION WITH CARDIAC MAGNETIC RESONANCE FOR ASSESSMENT OF LEFT VENTRICULAR FUNCTION AND VOLUMES IN A MODEL OF MYOCARDIAL INFARCTION (2012) (4)
Genetic maneuvers to ameliorate ventricular function in heart failure: therapeutic potential and future implications (2005) (4)
Is contractility depressed in the failing human heart? (1995) (4)
Sarco/Endoplasmic Reticulum Ca2+-ATPase is a more effective calcium remover than Sodium-Calcium Exchanger in human embryonic stem cell-derived cardiomyocytes. (2019) (4)
Direct Myocardial Injection of Vectors. (2017) (4)
Anellovirus Structure Reveals a Mechanism for Immune Evasion (2022) (4)
Overexpression of sorcin improves cardiac excitation-contraction coupling in normal and failing ventricular cardiomyocytes (2003) (4)
Rescue of Ca2+ Overload-induced Left Ventricle Dysfunction by Targeted Ablation of Phospholamban (2005) (4)
Tracking cell therapy: bioluminescence lighting the way. (2012) (4)
Targeting signaling pathways in heart failure by gene transfer (2003) (4)
Modulating signaling pathways in hypertrophy and heart failure by gene transfer. (2002) (4)
Gene editing reverses arrhythmia susceptibility in humanized PLN-R14del mice: modeling a European cardiomyopathy with global impact. (2022) (4)
Inhaled Gene Transfer for Pulmonary Circulation. (2017) (4)
Pulmonary hypertension arising from left heart disease causes intrapulmonary venous arterialization in rats. (2018) (4)
Myofibrillar responsiveness to cAMP, PKA, and caffeine in an animal model of heart failure. (2003) (4)
Cardiac signal transduction (2000) (4)
Modeling Pulmonary Hypertension: A Pig Model of Postcapillary Pulmonary Hypertension. (2018) (4)
A novel efficient percutaneous myocardial gene delivery system (2002) (4)
Stem cell and gene therapy for cardiac regeneration (2014) (4)
Reduced longitudinal contraction is associated with ischemic mitral regurgitation after posterior MI. (2018) (4)
transcription factor NFAT and proliferation in human vascular smooth muscle cells (2011) (4)
Preclinical animal models for testing iPSC/ESC-based heart therapy (2012) (3)
Genetic editing of dysfunctional myocardium. (2003) (3)
Catheter‐based ventricle‐coronary vein bypass (2005) (3)
Adenoviral gene transfer of SERCA2a improves iv function in aortic-banded rats in transition to heart failure (1998) (3)
Characterization of the Differential Progression of Left Ventricular Remodeling in a Rat Model of Pressure Overload Induced Heart Failure. Does Clip Size Matter? (2018) (3)
Abstract 20916: Therapeutic Cardiac-Targeted Delivery of Mir-1 Reverses Hypertrophy and Preserves Cardiac Function in a Pressure Overload Animal Model. (2010) (3)
Novel Approaches to Deliver Molecular Therapeutics in Cardiac Disease Using Adeno-Associated Virus Vectors (2012) (3)
Swine Model of Mitral Regurgitation Induced Heart Failure. (2018) (3)
Coronary capillary blood flow in a rat model of congestive heart failure. (2018) (3)
Echocardiographic Left Ventricular Mass Estimation: Two-Dimensional Area-Length Method is Superior to M-Mode Linear Method in Swine Models of Cardiac Diseases (2019) (3)
Targeted SERCA2a Gene Delivery to Restore Electrical Stability in the Failing Heart (2012) (3)
Differences in Cardioprotective Efficacy of Adrenergic Receptor Antagonists and Ca 21 Channel Antagonists in an Animal Model of Dilated Cardiomyopathy (2005) (3)
Monday, 27 August 2012 (2012) (3)
Revisiting Old Players in the Revitalized Field of Cardiovascular Gene Therapy. (2015) (3)
Myocardial Cannabinoid Receptor Imaging in Obesity. (2018) (3)
Gene Transfer to Rodent Hearts In Vivo. (2017) (3)
The promise of gene therapy as a therapeutic modality in heart failure. (2000) (3)
Induction and Characterization of Pulmonary Hypertension in Mice using the Hypoxia/SU5416 Model. (2020) (3)
A Decoy Peptide Targeted to Protein Phosphatase 1 Attenuates Degradation of SERCA2a in Vascular Smooth Muscle Cells (2016) (2)
Antisense strategies for treatment of heart failure. (2005) (2)
Gene Transfer in Cardiomyocytes Derived from ES and iPS Cells. (2017) (2)
Orthotopic heart transplantation in patients with cardiac amyloidosis (2005) (2)
Cardiac fibrosis and miR-433. (2016) (2)
Abstract 18618: Endothelial to Mesenchymal Transition Contributes to Atherosclerotic Plaque Formation and Correlates With Plaque Instability (2016) (2)
overload-induced cardiac hypertrophy Gene profiling during regression of pressure (2015) (2)
Abstract 20344: CCN5 Reverses Fibrosis and Cardiac Dysfunction Induced by Pressure Overload in Murine Models (2014) (2)
The matricellular protein CCN5 prevents adverse atrial structural and electrical remodelling (2020) (2)
Abstract 18442: Modeling Drug-Induced Long QT Syndrome with Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes (2014) (2)
Improved recovery of ventricular contractility with injection of self-assembling peptide nanofiber scaffolds after myocardial infarction in a rat model (2009) (2)
Abstract 12012: Dysregulated Adenosine Methylation of RNA in Myocardial Ischemia (2016) (2)
Magnetic resonance assessment of myocardial perfusion via catheter‐based ventricle–coronary vein bypass in porcine myocardial infarction model (2006) (2)
Abstract 919: Neonatal Gene Transfer of SERCA2a Alters Hypertrophic Gene Expression and Improves the Response to {beta}-Adrenergic Stimulation in a FHC {alpha}-Tropomyosin (Glu180Gly) Mouse Model (2006) (2)
Abstract 5331: Gene Transfer Of The Peripheral Type Benzodiazepine Receptor Alters The Spatio-temporal Dynamics Of The Mitochondrial Membrane Potential ({Delta}{Psi}M) Across The Intact Heart (2008) (2)
Technique of Complete Heart Isolation with Continuous Cardiac Perfusion During Cardiopulmonary Bypass: New Opportunities for Gene Therapy. (2018) (2)
Program and abstracts for the 2012 Joint Meeting of the Society for Glycobiology & American Society for Matrix Biology (2012) (2)
Chronic Pulmonary Artery Embolization Models in Large Animals. (2018) (2)
Protein kinase C activation in human ventricular myocardium. (1991) (2)
Abstract 1083: Targeted SERCA2a Gene Overexpression Identifies Mechanism and Potential Therapy for Arrhythmogenic Cardiac Alternans (2007) (2)
Direct measurement of left atrial and pulmonary artery pressure in rats with pulmonary hypertension. (2018) (2)
Abstract 16977: MicroRNA-mediated Regulation of SUMO1 Expression in Heart (2014) (2)
Abstract 18200: Intracoronary Delivery of Bioabsorbable Alginate Matrix (IK-5001) Ameliorates Adverse Post-infarction Left Ventricular Remodeling and Improves Left Ventricular Function in a Porcine Model of Reperfused Myocardial Infarction (2015) (2)
Restoration of contractile function in isolated failing human ventricular cardiac myocytes by gene transfer of SERCA2a (1999) (2)
Sterile Abscess in the Myocardium after Direct Intramyocardial Injection Related to Gene Therapy in a Swine Model (2011) (2)
230. In Vivo Fluorescence Tracking System for Cardiac Stem Cell Therapy (2006) (2)
Dynamic but discordant alterations in zDHHC5 expression and palmitoylation of its substrates in cardiac pathologies (2022) (2)
ALTERED Ca2+ CYCLING IN RAT HEART DURING SPESIS (2003) (2)
Gene and protein-based therapies for improving cardiac performance and regeneration (2020) (2)
Manipulation of SERCA2a in the heart by gene transfer (2000) (2)
Abstract 16566: T1 Mapping Calculated from Look-Locker Sequences Reliably Assesses Interstitial Myocardial Fibrosis Compared with Histology, and Diastolic Dysfunction (2012) (1)
Resistin Promotes Cardiac Hypertrophy via AMPK / mTOR and JNK / IRS 1 Pathways (2011) (1)
Myofilament Alterations Associated with Human R14del-Phospholamban Cardiomyopathy (2023) (1)
Accuracy of Non-fluoroscopic Catheter-based Electromechanically-guided (NOGA) Mononuclear Cell Endocardial Injection in a Swine Myocardial Infarction Model Assessed by MRI (2009) (1)
In silico Cell Therapy Model Restores Failing Human Myocyte Electrophysiology and Calcium Cycling in Fibrotic Myocardium (2022) (1)
Abstract 18434: Modulation of N6-Methyladenosine (m6A) as a Novel Mechanism of Human CD34+ Stem Cell-Derived Exosomes in Cardiac Repair (2017) (1)
Abstract 17367: Infusion of the Ketone Body β-Hydroxybutyrate Improves Left Ventricular Systolic Function in an Animal Model of Heart Failure With Reduced Ejection Fraction (2018) (1)
Efficient Viral Gene Transfer to Rat Hearts In Vivo (2011) (1)
Calcium Homeostasis in Human Heart Failure (1998) (1)
MicroRNA-25 upregulation protects spinal cords, yet is bad for the heart: The dark side of noncoding RNAS. (2019) (1)
[Hopes for gene therapy for cardiac failure]. (2006) (1)
Endo-bronchial aerosolized AAV1.SERCA2a gene therapy in a pulmonary hypertension pig model: addressing the lung delivery bottleneck. (2022) (1)
Differential effects of cAMP and protein kinase A on sacroplasmic reticulum Ca2+uptake in falling and nonfalling human myocardium (1996) (1)
Of Mice and Men. (2018) (1)
Abnormal sarcoplasmic reticulum Ca2+activity and uptake in human heart failure (1996) (1)
Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai Translational Mission. (2017) (1)
Targeting genes and cells in the progression to heart failure. (2005) (1)
Reply to "Letter to the editor: Characterizing preclinical model of ischemic heart failure: difference between LAD and LCx infarctions". (2015) (1)
Abstract 17984: Validating the Gold-standard: Steady-State Free Precession Sequence for Assessment of Left Ventricular and Right Ventricular Mass (2014) (1)
Child Health Promotion in UnderservedCommunities (2019) (1)
Abstract 17407: Modulation of N6-Methyladenosine (m6A) by the Fat Mass Obesity-Associated Gene (FTO) Regulates Cardiac Function (2017) (1)
Corrigendum to “Dominant negative Ras attenuates pathological ventricular remodeling in pressure overload cardiac hypertrophy” [Biochim. Biophys. Acta 1853/11 (2015) 2870–2884] (2016) (1)
Abstract 104: AAV-Exosomes: A Novel Platform for Myocardial Gene Delivery for Cardioprotection (2018) (1)
Abstract 18088: Myocardial Delivery of Lipidoid Nanoparticle mRNA Designed for Tailored Expression of Cardiogenic Factors (2013) (1)
Abnormal Calcium Metabolism in Heart Muscle Dysfunction (1993) (1)
Abstract 3911: A Novel Small Molecule Approach for Treating Mechano-electrical Dysfunction in Heart Failure (2009) (1)
Intra-scar perfusion heterogeneity by cardiac magnetic resonance in a porcine model of non-reperfused myocardial infarction. (2014) (1)
Cardiovascular Gene Therapy (2013) (1)
Animal model of left atrial thrombus in congestive heart failure in rats. (2019) (1)
Multimodality Imaging of Chronic Ischemia (2010) (1)
Abstract 3807: Chronic Cardiac-Targeted RNA Interference for the Treatment of Severe Heart Failure Restores Cardiac Function and Reduces Pathological Hypertrophy (2008) (1)
Abstract 2704: Early Repair of Moderate Ischemic MR Reverses LV Remodeling: A Functional and Molecular Study (2006) (1)
Cardiac gene therapy: Kick-starting calcium cycling in rats (2005) (1)
Abstract 3669: Transcoronary Gene Transfer of Serca2a Enhances Coronary Blood Flow through an Increase of eNOS Activity in Endothelial Cells (2008) (1)
Abstract 746: The Effect of Aging-related Metabolic Disorder on Resistin Expression and Valvular Heart Disorder (2019) (1)
THE SGLT2 INHIBITOR EMPAGLIFLOZIN IMPROVES DIASTOLIC FUNCTION IN A HEART FAILURE MODEL MEDIATED VIA ENHANCED MYOCARDIAL KETONE METABOLISM (2019) (1)
CUPID 1: MYDICAR® in Patients With Advanced Heart Failure Continue to Demonstrate Improvement in Clinical Outcomes Compared to Optimal Therapy 9 Months Post-Dose (2010) (1)
1029-22 Effect of Cyclic GMP in Human Myocardium: Role of cAMP/cGMP Balance (1995) (1)
Abstract 16448: Adult Human Cardiac Progenitor Cells Enhance Contractile Force in Human Engineered Cardiac Tissues (2018) (1)
237. Gene Expression Profiles in Diabetic Cardiomyopathy Following SERCA2a Gene Transfer (2006) (1)
in vivo Tracking and Effects of SPIO‐labeled Mesenchymal Stem Cells in a Porcine Model of Abdominal Aortic Aneurysm (2015) (1)
Titin--springing back to youth? (2002) (1)
Adult human cardiac stem cell supplementation effectively increases contractile function and maturation in human engineered cardiac tissues (2019) (1)
Abstract P482: Elucidating And Characterizing The Molecular Mechanistic Role Of Phospholamban L39 Stop In The Pathophysiology Of Cardiomyopathy Using Patient-derived Human Induced Pluripotent Stem Cells And Humanized Knock-in Mouse Model Systems (2021) (1)
Human anelloviruses produced by recombinant expression of synthetic genomes (2022) (1)
Abstract 16186: Hypoxic Pre-conditioning on Human CD34+ Stem Cells Enhances Exosome Therapeutics of Ischemic Tissue Repair Through ETS-1-Regulated Pathway (2015) (1)
Abstract 12: M6A Modification in RNA Regulates Cardiomyocyte and Cardiac Function in Heart Failure (2017) (1)
Isoform changes of action potential regulators in the ventricles of arrhythmogenic phospholamban-R14del humanized mouse hearts. (2022) (1)
Chapter 46 – Cardiac Gene Therapy (2012) (1)
Abstract 10667: Long Term Follow-up of Patients With Advanced Heart Failure Following a Single Intracoronary Infusion of Aav1/serca2a (2013) (1)
Abstract 18698: Identification of a Novel Cardiac Progenitor Population Expressing Pw1/peg3 in the Murine Heart (2014) (1)
Adverse effects of hydroxychloroquine and azithromycin on contractility and arrhythmogenicity revealed by human engineered cardiac tissues (2021) (1)
Scar Size and Other Parameters for Tracking Left Ventricular Dysfunction after Induction of Myocardial Infarcts in Sheep (Ovisaries). (2018) (1)
Inflammation and Heart Failure: Friend or Foe? (2021) (1)
Abstract 18635: Development of a Swine Model of Chronic Postcapillary Pulmonary Hypertension: Long Term Characterization by Cardiac Catheterization, Magnetic Resonance and Pathology (2013) (1)
Modulation of chromatin remodeling proteins SMYD1 and SMARCD1 promotes contractile function of human pluripotent stem cell-derived ventricular cardiomyocyte in 3D-engineered cardiac tissues (2019) (0)
Lentiviral-Mediated Interleukin-10 Gene Therapy for Lung Transplantation. (2019) (0)
Heart Failure Targeted Sarcoplasmic Reticulum Ca ATPase 2a Gene Delivery to Restore Electrical Stability in the Failing Heart (2012) (0)
Deletion Of P 53 In Endothelial Cells Prevents Cardiac Fibrosis And Heart Failure Induced By Pressure Overload In Mice Via Enhanced Angiogenesis (2013) (0)
Abstract 16892: Beneficial Effect of miR-25 Decoy Overexpression in a Murine Model of Heart Failure (2014) (0)
Abstract 19040: Exome Sequencing of Extreme Phenotypes Identifies B4GALT2 as a Determinant of Clopidogrel Response Variability (2014) (0)
The Regenerative Potential of Mesenchymal Stem Cells in a Porcine Abdominal Aortic Aneurysm Model (2013) (0)
Intratracheal Gene Delivery of SIN3A Inhibits Pulmonary Arterial Hypertension and Restores BMPR2 Expression (2020) (0)
Phospholamban down-regulation or SERCA2a overexpression: Interaction with βAR stimulation in rabbit myocytes (2001) (0)
Abstract 17897: Pharmacological Inhibition of PTEN Increases Myocardial Salvage, Reduces Infarct Size, and Decreases Adverse Post-infarction Left Ventricular Remodeling in a Porcine Model of Reperfused Myocardial Infarction (2014) (0)
Rescue of Ca 2 (cid:1) overload-induced left ventriclur dysfunction by targeted ablation of phospholamban (2009) (0)
Abstract 18964: Resveratrol Prevents Iron-overload Cardiomyopathy by up Regulating Serca2a and by Exerting Anti-oxidant Effects (2014) (0)
118. In Vivo Tracking of Long Term Gene Expression of AAV1 Using Fluorescence Imaging System (2006) (0)
Abstract 142: Modeling Drug-Induced Long QT Syndrome with Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes (2013) (0)
Abstract 17357: Direct Cardiac Reprogramming Using Combinatorial Modified mRNA (2020) (0)
Abstract 20214: Ethnic Disparities in Metabolic Syndrome Among Caregivers of Preschool Children in a Community-Based Trial (2017) (0)
Therapeutic Targeted Delivery of AAV9 Sh BNIP3 Reverses Cardiac Remodeling and Improves Diastolic and Systolic Function in a Rat Model of Pressure Overload Induced Heart Failure (2012) (0)
Abstract 113: SUMO1 Gene Transfer Rescues Cardiac Function in a Large Animal Model of Heart Failure (2012) (0)
QS243. Analysis of Cell Based Therapy for Abdominal Aortic Aneurysms: Results of a Pilot Study in a Porcine Model (2009) (0)
Gene and cell therapy in heart failure. (2005) (0)
Anti- and proarrhythmic effects of cardiac assist device implantation (2011) (0)
Synergistic Role of Protein Phosphatase Inhibitor 1 and SERCA2a in the Acquisition of the Contractile Phenotype of Arterial Smooth Muscle Cells (2013) (0)
STEM CELL FACTOR OVER–EXPRESSION IMPROVES CARDIAC FUNCTION AFTER MYOCARDIAL INFARCTION IN SWINE (2013) (0)
Intratracheal SERCA2a Gene Therapy Interrupts the Formation of Plexiform Lesions and Rescues from Heart Failure in Severe Pulmonary Arterial Hypertension (2019) (0)
Abstract 16635: Real Time 3d Echocardiography is Comparable to Cardiac Mri in Reducing Sample Size Required to Assess Changes in Lv Function (2012) (0)
Tilemann Model of Heart Failure Gene Transfer Improves Cardiac Function in a Large-Animal SUMO-1 (2013) (0)
Abstract 15984: Alternatively Spliced Tissue Factor Exerts Greater Angiogenic Potency than Full-Length Tissue Factor via HIF-1a Induction in Complicated Atherosclerotic Plaques (2013) (0)
Abstract 842: Potential Role of MicroRNAs in the Pathogenesis of Diabetic Cardiomyopathy (2008) (0)
P936Yin-Yang 1 transcription factor modulates sST2 on adverse cardiac remodeling post-myocardial infarction (2018) (0)
Backx Molecular components of transient outward potassium current in cultured neonatal rat ventricular myocytes (0)
PS196. Tracking the Migration of Porcine Mesenchymal Stem Cells with the MRI Contrast Agent Ferex in an AAA Model (2012) (0)
1029-175 Anti-ErbB2 modulation of Bcl-xL/Bcl-xScauses mitochondrial dysfunction and apoptosis (2004) (0)
Abstract 943: In Vivo Assessment of Mesenchymal Stem Cells Fate Following Intracoronary Delivery (2006) (0)
Abstract 3805: Hemodynamic and Molecular Effects of Resistin Overexpression on Cardiovascular Function In Vivo (2008) (0)
AAV meets exosomes: at the cutting edge of cardiovascular gene therapy (2018) (0)
LOW DOSE ASPIRIN FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE: USE PATTERNS AND IMPACT ACROSS RACE IN THE SOUTHERN COMMUNITY COHORT STUDY (2018) (0)
A first-in-human phase 1 clinical gene therapy trial for the treatment of heart failure using a novel rationally designed cardiotropic adeno-associated vector (2022) (0)
Cable Tension Optimization for an Epicardial Parallel Wire Robot (2023) (0)
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR ACTIVATION WITH LIRAGLUTIDE DURING MYOCARDIAL ISCHEMIA DECREASES INFARCT SIZE AND IMPROVES SYSTOLIC LEFT VENTRICULAR FUNCTION (2013) (0)
Abstract 431: The Capillaries in Ischemic Border Zone: Origin And Role in Myocardial Infarction and Heart Failure (2019) (0)
Abstract 530: Mechanisms Underlying Phospholamban L39 Stop (PLN L39X) Cardiomyopathy (2020) (0)
Coronary heart disease In vivo myocardial distribution of multipotent progenitor cells following intracoronary delivery in a swine model of myocardial infarction (2009) (0)
Abstract 123: SUMO1 Modification Regulates SR Calcium ATPase Pump, SERCA2a in Heart Failure (2012) (0)
BCVS scientific conference 2012 meeting report. (2012) (0)
P374Expression pattern of sarco (endo) plasmic reticulum calcium atpases (SERCA) isoforms in normal and diseased mouse cardiovascular tissues (2014) (0)
Phosphorylation regulates association of PDE3A isoforms with distinct interactomes (1013.23) (2014) (0)
Inhibition of PKC (cid:1) / (cid:2) With Ruboxistaurin Antagonizes Heart Failure in Pigs After Myocardial Infarction Injury (2011) (0)
Abstract 373: An Animal Model of Left Atrial Thrombus (2018) (0)
Abstract 18587: Downregulation of Pulmonary Artery Endothelial Catechol-o-methyltransferase Activity by Aldosterone Increases Norepinephrine Levels in Pulmonary Arterial Hypertension (2014) (0)
Racial Disparities in Early Subclinical Atherosclerosis: Insights from the FAMILIA Study (2018) (0)
Abstract 18398: Prevention of Pulmonary Hypertension with Intra-tracheal Delivery of AAV1.SERCA2A (2010) (0)
919-12 Transient Wall Motion Abnormalities Following Rotational Coronary Atherectomy are Reflective of Myocardial Stunning More than Microinfarction (1995) (0)
Abstract 486: Increased Afterload In Sub-acute Phase Of Myocardial Infarction Exacerbates Heart Failure (2013) (0)
P1-6: Attenuation of cardiac hypertrophy by transient outward K+ current (2006) (0)
Editorial Board (2009) (0)
Abstract 17732: Identification of Stromal Interaction Molecule 1 Complexes in Cardiac Hypertrophy (2014) (0)
Targeting the SERCA-PLB Complex for Treatment of Heart Failure (2016) (0)
Abstract 12379: Glucagon-Like Peptide-1 Receptor Activation During Myocardial Ischemia Causes Short- and Long-Term Improvements in Myocardial Infarction Size and Left Ventricular Function (2011) (0)
776-6 Myocardial Adenylyl Cyclase Activity in an Animal Model of Dilated Cardiomyopathy Treated Chronically with the Non-Selective β-blocker Carteolol (1995) (0)
Author response: Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells (2016) (0)
Abstract 129: Human Mesenchymal Stem Cells Augment Contractile Function of Human Engineered Cardiac Tissues (2013) (0)
Abstract P281: A Novel Mutation in Adiponectin Receptor 1 Contributes to Cardiac Hypertrophy and Cardiometabolic Dysregulation (2014) (0)
776-6 Myocardial Adenylyl Cyclase Activity in an Animal Model of Dilated Cardiomyopathy Treated Chronically with the Non-Selective β-blocker Carteolol (1995) (0)
Abstract 10631: Exosome-Encapsulated Adeno-Associated Viruses as a Novel Cardiotropic Vector for Gene Therapy in Heart Failure (2021) (0)
Abstract 229: Increased Afterload Following Myocardial Infarction Promotes Conduction-dependent Arrhythmias That are Unmasked by Hypokalemia (2016) (0)
Regulation of cardiac function in human heart failure (1991) (0)
Expression of cardiac specific genes and functional testing of engineered cardiac tissues (2011) (0)
zDHHC5 expression is increased in cardiac hypertrophy and reduced in heart failure but this does not correlate with changes in substrate palmitoylation (2022) (0)
3213 Unraveling the role of Phospholamban (PLN) in humans via the characterization of Induced Pluripotent Stem Cell (iPSC) Cardiomyocytes (CM) derived from carriers of a lethal PLN mutation (2019) (0)
Structure-Based Design of Phospholamban Mutants for Gene Therapy (2010) (0)
Abstract 12131: Mechanism of Hypokalemia-dependent Arrhythmias in a New Porcine Model of Advanced Heart Failure: Insights Into the Pathophysiology of Increased Afterload in Chronic Myocardial Infarction (2015) (0)
SDF-1 induces TNF-mediated apoptosis in cardiac myocytes (2017) (0)
48. The Long-Term Effects of SERCA2a Overexpression in Large Animal Model of Heart Failure (2005) (0)
Abstract 10315: The Role of Perivascular Fibrosis in Non-infarcted Myocardium in Congestive Heart Failure in Rats. (2010) (0)
Abstract 3803: Myocardial CXCR4 Gene Transfer Negatively Modulates Cardiac Function Following Ischemia-Reperfusion Injury (2008) (0)
Gene Therapy for Cardiovascular Diseases (2016) (0)
Abstract 3864: MicroRNA-152 Represses SERCA2a and Contributes to the Impairment of Cardiomyocyte Contractile Function (2009) (0)
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR ACTIVATION DURING MYOCARDIAL INFARCTION REDUCES DIASTOLIC DYSFUNCTION IN PIGS (2012) (0)
LV UNLOADING USING AN IMPELLA CP IMPROVES CORONARY FLOW AND INFARCT ZONE PERFUSION (2017) (0)
Title Distinct roles of microRNA-1 and-499 in ventricular specification and functional maturation of human embryonic stem cell-derived cardiomyocytes (2011) (0)
The role of cAMP/PKA signaling enhancer Protein Phosphatase Inhibitor 1 (I‐1) in the control of Ca2+ cycling and signaling in VSMCs (2012) (0)
49. Evaluation of Catheter-Based Deliveries of 10um Gelatin Hydrogel Microsphere, a Novel Non-Viral Vehicle, in a Porcine Heart (2005) (0)
Mesenchymal Stem Cells Enhance Contractile Function of Myocyte-Depleted Engineered Cardiac Tissues (2010) (0)
P4352Gut microbiota and its dependent metabolite Trimethylamine N-oxide (TMAO) exacerbate adverse post-infarction left ventricular remodeling (2017) (0)
CARDIAC SPECIFIC PROMOTER FOR MYOCARDIAL GENE TRANSFER (2003) (0)
Abstract 222: CCN5 Overexpression Triggers Early Amplification Followed by Regression of Electrical Remodeling in a Pressure Overload Rat Model (2015) (0)
Abstract 468: The Role of Ca2+/PKA Signaling Enhancer Protein Phosphatase Inhibitor 1 in the Control of Ca2+ Cycling and Signaling in VSMCs (2012) (0)
CINE BALANCED STEADY-STATE FREE PRECESSION IS A RELIABLE ALTERNATIVE TO CONVENTIONAL T2-WEIGHTED IMAGING AND EVANS BLUE FOR THE CMR ASSESSMENT OF AREA AT RISK AFTER MYOCARDIAL INFARCTION (2013) (0)
Pathogenesis of Heart Failure (2005) (0)
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR ACTIVATION REDUCES COMPENSATORY HYPERTROPHY AND LEFT VENTRICULAR REMODELING IN A PORCINE MODEL OF ISCHEMIA AND REPERFUSION (2012) (0)
Basal Ca2+ Entry Controls NFAT Transcriptional Activity, Proliferation And Migration Of Human Vascular Smooth Muscle Cells (2009) (0)
Abstract 15068: Expression of PW1 Identifies a New Candidate Cardiac Progenitor Population in the Adult Heart (2015) (0)
Abstract 403: Tracking the Migration of Porcine Mesenchymal Stem Cells with the MRI Contrast Agent Ferex in an AAA Model (2012) (0)
Abstract 14053: The Sphingosine 1-phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Post-infarction Left Ventricular Remodeling in a Porcine Model of Reperfused Myocardial Infarction (2013) (0)
Recent Results of Cardiac Gene Therapy Clinical Trials (2016) (0)
Abstract 256: mRNA-based Nanoparticles Are Highly Effective Agents For Cardiac Gene Therapy (2013) (0)
Stem Cell Factor Gene Transfer Improves Cardiac Function After Myocardial Infarction in Swine Ishikawa et al: SCF Gene Therapy Improves Cardiac Function (2014) (0)
Abstract 20347: Does Electrophysiological Toxicity Limit the Therapeutic Window of Serca2a Gene Therapy? (2014) (0)
Engineering micro-alignments of 2- and 3-D hESC-derived ventricular tissues to reproduce anisotropic properties of the native heart: an accurate arrhythmias model for cardiotoxicity screening (2011) (0)
Abstract 312: STIM1 And The Development Of Pressure-overload Induced Cardiac Hypertrophy In Rodents (2013) (0)
Abstract 15794: Glucagon-Like Peptide-1 Receptor Activation Improves Systolic LV Function and LV Mechanics in a Porcine Model of Ischemia and Reperfusion (2012) (0)
Labeling of Mesenchymal Stem Cells with Gadolinium Using Biodegradable Gelatin as a Transfection Agent (2005) (0)
P.314Pharmacological activation of SERCA2a SUMOylation improves cardiac function and pathology in models of Duchenne muscular dystrophy (2019) (0)
Abstract 326: FTO-mediated mRNA Demethylation Regulates Cardiac Contractile Protein Expression and Function (2019) (0)
INCREASED EXPRESSION OF ADIPOKINE–RESISTIN EXPRESSION IN LIPID–RICH ATHEROMATOUS PLAQUES WHEN COMPARED TO LIPID POOR–FIBROTIC PLAQUES IN HUMAN ATHEROSCLEROSIS–IMPLICATION IN ACCELERATED ATHEROSCLEROTIC LESION PROGRESSION (2013) (0)
Abstract 382: p300 Mediated Acetylation of the Cardiac Calcium Pump Reduces Its Activity and Contributes to Cardiac Dysfunction (2017) (0)
Abstract 2732: Stabilisation of SR Leak in Heart Failure After SERCA2a Gene Therapy (2009) (0)
Results of a Pre-Clinical Trial of Periostin Peptide in Myocardial Infarction (2009) (0)
Abstract 5778: Protein Phosphatase 1 Signalling Pathway is Involved in the Control of Vascular Smooth Muscle Cells Proliferation (2009) (0)
Abstract MP165: Exosome-mediated Encapsulation Alters AAV Antigenicity and Infectivity: Implications for Gene Delivery in the Heart (2020) (0)
Canadian Journal of Cardiology Symposium Review Targeted Gene Therapy for the Treatment of Heart Failure (2011) (0)
MYD88 IS INDISPENSABLE FOR PEPTIDOGLYCAN-ASSOCIATED LIPOPRPTEIN (PAL) -INDUCED DYSFUNCTION AND DEATH IN MOUSE CARDIOMYOCYTES.: 57 (2005) (0)
Abstract 275: Electrophysiological Consequences of AAV9 mediated SERCA2a Gene Transfer to Normal Rat Myocardium (2014) (0)
Abstract 16719: STIM1 Inhibits GSK3-Beta to Maintain Cardiac Hypertrophy in a Murine Pressure Overload Induced Heart Failure Model (2014) (0)
Abstract 301: An m6A Demethylase, FTO Mediates Post-transcriptional mRNA Modifications to Regulate Cardiac and Cardiomyocyte Function (2018) (0)
overexpression of phospholamban with use of adenovirus Functional alterations in adult rat myocytes after (2013) (0)
Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes (2014) (0)
Abstract 3231: Recombinant Periostin Peptide Improves Myocardial Function and Decreases Scar Size in a Preclinical Infarct Model (2009) (0)
THE SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST FINGOLIMOD REDUCES ISCHEMIA-REPERFUSION INJURY BY DECREASING CARDIOMYOCYTE APOPTOSIS MEDIATED BY ACTIVATION OF THE RISK PATHWAY (2015) (0)
Abstract 170: Exosomal AAV-mediated SERCA2a Gene Transfer Improves Cardiac Function in a Mouse Model of Heart Failure (2019) (0)
, Claudia and VEGF Signaling α HIF-1 Alternatively Spliced Tissue Factor Promotes Plaque Angiogenesis Through the Activation of (2014) (0)
adenovirusof phospholamban with use of Functional alterations in adult rat myocytes after (2015) (0)
THE ACTIVATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR BY FINGOLIMOD DURING MYOCARDIAL INFARCTION IMPROVES DIASTOLIC FUNCTION IN PIGS (2014) (0)
cardiomyopathy in swine Development of a preclinical model of ischemic (2011) (0)
ALTERNATIVELY SPLICED TISSUE FACTOR IS HIGHLY EXPRESSED IN COMPLEX HEMORRHAGIC CAROTID AND CLINICALLY UNSTABLE CORONARY PLAQUES (2013) (0)
Inhibiting miR-25 Through Tough Decoy Gene Transfer Improves Calcium Handling and Cardiomyocyte Contractility in Aged MDX/UTRN KO Mice (2017) (0)
850. Efficiency of Six AAV Serotypes in Transducing Rat Myocardium In Vivo (2005) (0)
Abstract 8142: By Virtue of Its Interaction with the {beta}2-adrenergic Receptor, CXCR4 Plays a Role in the Regulation of {beta}2-adrenergic Receptor Signaling Pathway Affecting Calcium and Contractility in Cardiac Myocytes (2011) (0)
Abstract 447: The Role of Extracellular cAMP in the Pathogenesis of Pulmonary Arterial Hypertension (2018) (0)
A role for calcium in resistin transcriptional activation in diabetic hearts (2018) (0)
Abstract 14545: Glucagon-Like Peptide-1 Receptor Activation With Liraglutide During Acute Myocardial Infarction Improves Myocardial Salvage and Systolic Left Ventricular Function (2013) (0)
Targeted Gene Therapy with RXFP1 Attenuates Myocardial Infarction and Preserves Left Ventricular Function in Mice (2018) (0)
SERCA2A GENE TRANSFER INHIBITS PROGRESSIVE LV REMODELING IN POST MI CHRONIC HEART FAILURE (2014) (0)
The heart of the matter (2011) (0)
Ning Sun Dilated Cardiomyopathy Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial (2012) (0)
45. Adenoviral Gene Transfer of SERCA2a Restores Mechanical and Energetic Left-Ventricular Function in Spontaneously Diabetic Rats (2005) (0)
Abstract 510: Extracellular cAMP as a Novel Therapeutic Strategy in Pulmonary Arterial Hypertension (2018) (0)
Integrative Physiology Inhibition of PKC / With Ruboxistaurin Antagonizes Heart Failure in Pigs After Myocardial Infarction Injury Short Communication (2011) (0)
The protein phosphatase 1 inhibitor-1: a potent “molecular inotrope” in cardiac function (2003) (0)
Molecules linked to Ras signaling as therapeutic targets in cardiac pathologies (2021) (0)
Abstract O-2: The Role of Post-translational Modifications in SERCA2a-related Cardiac Dysfunction (2014) (0)
Gene therapies for arrhythmias in heart failure (2014) (0)
Social determinants of lifestyle and cardiovascular health in a minority community study for promotion of health (2018) (0)
P932Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKC/Gal-3 signaling pathway attenuates adverse cardiac fibrosis, following myocardial infarction (2018) (0)
Regression of cardiac hypertrophy by cyclic guanosine monophosphate-dependent protein kinase signaling are myocytes active sources or mere beneficiaries? (2010) (0)
Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice (2017) (0)
Abstract 185: Genome Editing of Isogenic Human Induced Pluripotent Stem Cells Allows for Functional and Transcriptomic Insights Into Hereditary Dilated Cardiomyopathy Caused by Phospholamban Mutations (2017) (0)
Gene therapy by SERCA2a for failing hearts in spontaneous type II DM model rats (2006) (0)
Targeting Diabetes with a Novel Small Molecule Activator of Sarco/endoplasmic Reticulum Ca2+‐ATPase (SERCA) (2013) (0)
Abstract 3174: Administration of Cyclin A2 by Gene Transfer Improves Cardiac Function in a Porcine Model of Myocardial Infarction (2009) (0)
Abstract 652: Coronary Capillaries in Ischemic Congestive Heart Failure in Rats Exhibit Significant Morphological Disorder (2015) (0)
Multi-Scale Biomechanics in a Marfan Syndrome Model of Dilated Cardiomyopathy (2014) (0)
1042. Tracking and Gene Expression Profile of Bone Marrow Mesenchymal Stem Cells Injected into Pig Myocardium by Magnetic Resonance Imaging and Laser-Capture Microdissection (2006) (0)
Highlighting the Field of Cardiovascular Regenerative Medicine. (2018) (0)
Abstract 10: Antifibrotic Effect of CCN5 in a Murine Model of Heart Failure (2012) (0)
BACTERIAL PEPTIDOGLYCAN-ASSOCIATED LIPOPROTEIN (PAL) INDUCES DYSFUNCTION IN CARDIOMYOCYTES THROUGH MYOCARDIAL TLR2 /MYD88.: 114 (2006) (0)
Abstract 16618: Pre-Gadolinium Inversion-Recovery Sequence: A Novel and Reliable Magnetic Resonance Method for Assessing Area at Risk (2012) (0)
Abstract 333: AAV9 Serca2a Gene Transfer Reverses Some but Not All Electrophysiological Deficits in a Chronic Model of Congestive Heart Failure (2015) (0)
LV UNLOADING USING IMPELLA CP IMPROVES LA PRESSURE, FUNCTION, AND STIFFNESS IN ISCHEMIC PIG MODEL (2017) (0)
Abstract 870: Cardiac Gene Therapy With Relaxin Receptor 1 Overexpression Protects Against Acute Myocardial Infarction and Associated Adverse Remodeling (2019) (0)
Reproducibility of Three-Dimensional Vascular Ultrasound for the Detection and Quantification of Early Atherosclerosis: A FAMILIA Substudy (2018) (0)
Cardiovascular Gene and Cell Therapy (2005) (0)
SUMOylation does not affect cardiac troponin I stability but alters indirectly the development of force in response to Ca2+ (2022) (0)
Abstract 313: STIM1 Silencing Reverses Pressure-overload Induced Cardiac Hypertrophy In Mice (2013) (0)
Gene Therapy for the Treatment of CPVT (2014) (0)
Abstract 206: Stem Cell-derived Exosomes Induce Cardiac Repair via mRNA Modification (2016) (0)
Ultra‐Compliant Indwelling Elastomer Balloons Improve Stability and Performance of Bioengineered Human Mini‐Hearts (2022) (0)
Tracking Cell Therapy: Bioluminescence Lighting the Way⁎⁎Editorials published in JACC: Cardiovascular Imaging reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Imaging or the American College of Cardiology. (2012) (0)
Integrative Cardiovascular Physiology and Pathophysiology Variability in coronary artery anatomy affects consistency of cardiac damage after myocardial infarction in mice (2017) (0)
ECHOCARDIOGRAPHICAL ASSESSMENT OF POST-REPERFUSION WALL THICKENING ACCURATELY QUANTIFIES THE AREA AT RISK: AN EXPERIMENTAL PORCINE STUDY VALIDATED WITH MAGNETIC RESONANCE AND HISTOLOGY (2014) (0)
Child Health Promotion in Underserved Communities: Primary Results From the Cluster Randomized FAMILIA Trial (2018) (0)
Targeting the Serca-Plb Complex using FRET in Living Cells (2017) (0)
Abstract 22: Identification of the Nature of Cardiac Resident c-kit+ Cells (2016) (0)
Solution NMR structures of CBP bromodomain with small molecule of HBS (2011) (0)
SERCA2a gene transfer reduces vascular smooth muscle cell proliferation in human arteries: A new target for restenosis? (2007) (0)
Abstract 18097: PTEN Inhibition With VO-OHPIC Ameliorates Myocardial Ischemia-Reperfusion Injury Mediated by RISK Pathway Activation-Mediated Reduction of Apoptosis: An in vitro and in vivo Study (2016) (0)
1116. Gene Transfert of SERCA2a Inhibits Smooth Muscle Proliferation and Reduce Neointima Formation after Balloon Injury in the Rat (2005) (0)
Adducin Regulates Sarcomere Disassembly During Cardiomyocyte Mitosis (2020) (0)
Abstract 259: Resistin Accelerates Fibroblast-Myofibroblast Differentiation and Induces Myocardial Fibrosis (2019) (0)
480 Role of the sarcoplasmic reticulum Ca2+ ATPase in the control of vascular smooth muscle cell proliferation (2003) (0)
P.316Adeno-associated virus mediated SUMO1 overexpression improves cardiac disease phenotype in mouse models of Duchenne muscular dystrophy (2019) (0)
In Situ Heart Isolation Featuring Closed Loop Recirculation: The Gold Standard for Optimum Cardiac Gene Transfer? (2017) (0)
THE SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST FINGOLIMOD REDUCES MYOCARDIAL ISCHEMIA-REPERFUSION INJURY MEDIATED BY ACTIVATION OF AUTOPHAGY: AN IN VITRO AND IN VIVO STUDY (2015) (0)
P4393Impella unloads left atrium and reduce atrial arrhythmogenicity (2017) (0)
Abstract 5372: In Vivo Myocardial Distribution of Adult Stem Cells Immediately Following Intracoronary Delivery in a Swine Model of Myocardial Infarction (2008) (0)
Targeting protein-protein interactions for therapeutic discovery via FRET-based high-throughput screening in living cells (2018) (0)
Abstract 18340: Alternatively Spliced Tissue Factor Promotes Atherosclerosis by Increasing Foam Cell Formation via LOX-1 and SR-A1 up-regulation (2015) (0)
Abstract 16109: A Selective Cargo of Non-coding RNAs Mediate Therapeutic Potential of Human CD34+ Stem Cell-derived Exosomes (2015) (0)
Left Ventricular Volume and Ejection Fraction Evaluation with Non-fluoroscopic Catheter-based Electromechanical Mapping (NOGA) and MRI (2009) (0)
Abstract 2882: Directed Evolution of Cardiac Specific Adeno-Associated Vector Variants (2008) (0)
Abstract 14976: Foxo3a Modulates Mitochondrial and Myocardial Function by Regulating Bnip3 Gene Expression in the Heart (2016) (0)
MISE AU POINT/IN-DEPTH REVIEW GENE AND CELL THERAPY IN HEART FAILURE (2005) (0)
Mesenchymal Stem Cells Potentiate Reparative Processes by Downregulation of Matrix Metalloproteinases 1, 3, and 9 in a Porcine Abdominal Aortic Aneurysm Model (2014) (0)
3444 Development of human engineered cardiac tissue (hECT)-based screening assay to explore cardiac contractile properties in response to pharmacological challenge with proarrhythmic drugs (2019) (0)
Identification and Characterization of p300-Mediated Lysine Residues in Cardiac SERCA2a (2023) (0)
STIM1 silencing prevents pressure‐overload induced cardiac hypertrophy in mice (2012) (0)
Abstract 16942: Alternatively Spliced Tissue Factor promotes plaque progression, inflammation and angiogenesis in experimental atherosclerosis (2014) (0)
Abstract 277: Lung Gene Transfer With Sarcoplasmic Reticulum Calcium ATPase Prevent Disease Progression in Pulmonary Arterial Hypertension (2018) (0)
Abstract 2095: Cardiac-targeted RNA Interference Against STIM1 Using a Recombinant AAV9 Vector Limits the Progression of Heart Failure in Rats (2009) (0)
SERCA2a Gene Therapy for Heart Failure (2016) (0)
2525 Development of human cell-based screening assays to detect subject-specific drug-response variability (2018) (0)
P6516Impact of pulmonary hypertension on the left ventricular stiffness: Pressure-volume relationship study (2018) (0)
Real-Time Imaging of Platelet-Rich Thrombi in Thick-Walled Blood Vessels Using Near-Infrared Fluorescence Light. (2006) (0)
Cardionomics:anewintegrative approachforscreening cardiotoxicityofdrugcandidates (2009) (0)
Abstract 584: FTO-Dependent m6A Regulates Cardiomyocyte and Cardiac Function During Remodeling and Repair (2018) (0)
Abstract 38: A Decoy Peptide Selectively Inhibiting Dephosphorylation of Phospholamban (2012) (0)
MYOCARDIAL OXYGENATION USING BLOOD LEVEL-OXYGEN DEPENDENT SEQUENCE IN MAGNETIC RESONANCE DETERMINES MYOCARDIAL ENERGETICS AND CAPILLARY DENSITY (2017) (0)
Spectroscopic Design of Phospholamban Mutants to Treat Heart Failure (2010) (0)
Abstract 130: The Diversity of Coronary Artery and Myocardial Infarction in Mice (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Roger J. Hajjar?

Roger J. Hajjar is affiliated with the following schools:

Roger J. Hajjar's Academic­Influence.com Rankings

Roger J. Hajjar's Degrees

Why Is Roger J. Hajjar Influential?

Roger J. Hajjar's Published Works

Published Works

What Schools Are Affiliated With Roger J. Hajjar?

Roger J. Hajjar's AcademicInfluence.com Rankings